secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001493152-26-000613
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic completes Tranche 3 of unit offering, raising $1.1M from 22 investors
-------------------------------------------------------------------------------

- Issued 44 units under final Tranche 3; each unit includes a $25,000 principal, 12% 2-year convertible note.
- Each note convertible into 250,000 shares of Oncotelic at $0.10 or 25,000 EdgePoint shares at $1.00.
- Each unit includes 250,000 warrants to purchase Oncotelic stock at $0.12 or EdgePoint warrants at $1.25.
- Prior 2023 PPM notes settled; existing warrants extended to two years from final closing.
- Registration Rights Agreement executed for shares and warrants issued in the financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/0001493152-26-000613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer